These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30244319)

  • 1. Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System.
    Luo Y; Wang XQ; Ni WJ; Ding B; Xu XH; Ye L; Ma JH; Zhu J
    Diabetes Ther; 2018 Dec; 9(6):2219-2228. PubMed ID: 30244319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System.
    Luo Y; Ni WJ; Ding BO; Xu XH; Ye L; Ma JH; Zhu J
    Diabetes Ther; 2019 Feb; 10(1):205-213. PubMed ID: 30610472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.
    Liu BL; Yin GP; Li FF; Hu Y; Wu JD; Chen MY; Ye L; Su XF; Ma JH
    Int J Endocrinol; 2018; 2018():2087960. PubMed ID: 29780415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type 2 diabetes using continuous glucose monitoring system.
    Li HQ; Lu CF; Wang J; Yin GP; Sun R; Xu XH; Liu BL; Li FF; Jing T; Lee KO; Ye L; Ma JH; Su XF
    J Endocrinol Invest; 2018 Feb; 41(2):179-184. PubMed ID: 28643298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study.
    Nishimura R; Tsujino D; Taki K; Morimoto A; Tajima N
    Cardiovasc Diabetol; 2010 May; 9():16. PubMed ID: 20438630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes.
    Zafar MI; Ai X; Shafqat RA; Gao F
    Ther Clin Risk Manag; 2015; 11():27-32. PubMed ID: 25565854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles.
    Li YJ; Shao ZY; Zhu YQ; Chen DS; Zhu J
    J Diabetes; 2024 Apr; 16(4):e13536. PubMed ID: 38599884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
    Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
    Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis.
    Jinnouchi H; Imori M; Nishiyama H; Imaoka T
    Diabetes Ther; 2020 Sep; 11(9):2075-2088. PubMed ID: 32728833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes.
    Meng Z; Xu C; Liu H; Gao X; Li X; Lin W; Ma X; Yang C; Hao M; Zhao K; Hu Y; Wang Y; Kuang H
    Front Endocrinol (Lausanne); 2023; 14():1272112. PubMed ID: 38027146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial.
    Li W; Ping F; Xu L; Zhou M; Li H; Dong Y; Li Y
    Diabetes Ther; 2018 Apr; 9(2):699-711. PubMed ID: 29520742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.
    Wang S; Tan Z; Wu T; Shen Q; Huang P; Wang L; Liu W; Song H; Lin M; Shi X; Li X
    Front Endocrinol (Lausanne); 2022; 13():858912. PubMed ID: 35498416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of ultra rapid lispro in the treatment of type 2 diabetes mellitus: a randomized controlled clinical trial].
    Chen S; Zhou J; Lu JY; Bao YQ; Xu JW; Zhu JK; Jia WP
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1093-1101. PubMed ID: 37650183
    [No Abstract]   [Full Text] [Related]  

  • 16. Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes.
    Liu BL; Liu XM; Ren YF; Sun YX; Luo MH; Ye L; Ma JH; Li FF
    J Diabetes Res; 2020; 2020():8152640. PubMed ID: 32090123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog
    Miura J; Imori M; Nishiyama H; Imaoka T
    Diabetes Ther; 2020 Sep; 11(9):2089-2104. PubMed ID: 32728832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial.
    Wang L; Liu X; Yang W; Lai J; Yu X; Liu J; Gao X; Ming J; Ma K; Xu J; Tian Z; He Q; Ji Q
    Diabetes Ther; 2020 Oct; 11(10):2313-2328. PubMed ID: 32856226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.
    Roach P; Yue L; Arora V
    Diabetes Care; 1999 Aug; 22(8):1258-61. PubMed ID: 10480767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
    Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG
    Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.